Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-06
2007-03-06
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252110, C514S253050, C514S254090, C514S218000, C544S121000, C544S357000, C544S363000, C544S373000, C540S575000
Reexamination Certificate
active
10466248
ABSTRACT:
The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
REFERENCES:
patent: 6294534 (2001-09-01), Nargund et al.
patent: WO 94 13696 (1994-06-01), None
patent: WO 99 55679 (1999-11-01), None
patent: WO 99 64002 (1999-12-01), None
patent: WO 00 74679 (2000-12-01), None
patent: WO 01 70337 (2001-09-01), None
patent: WO 01 70708 (2001-09-01), None
patent: WO 02 15909 (2002-02-01), None
patent: WO 02 059095 (2002-08-01), None
patent: WO 02 059107 (2002-08-01), None
patent: WO 02 059108 (2002-08-01), None
patent: WO 02 070511 (2002-09-01), None
Sebhat et al. Annual Reports in Medicinal Chemistry, vol. 38, p. 31-40 (2003).
Campfield et al. Science, vol. 280, p. 1383-1387 (1998).
Briner Karin
Doecke Christopher William
Mancuso Vincent
Martinelli Michael John
Richardson Timothy Ivo
Bernhardt Emily
Eli Lilly and Company
Jang Soonhee
Myers James B.
LandOfFree
Piperazine- and piperidine-derivatives as melanocortin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine- and piperidine-derivatives as melanocortin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine- and piperidine-derivatives as melanocortin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3795704